Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC

Opening the Floodgates to T Cells – Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC

kidneycancer

4 years
432 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Jeffrey Wallin, Ph.D. of Genentech presents "Opening the Floodgates to T Cells Biomarkers for the Combination of Bevacizumab and Atezolizumab in RCC" at the 14th International Kidney Cancer Symposium.
Up Next Autoplay